Insider buying last 90 days
No open-market insider purchases were filed for ACA in the last 90 days.
From Form 4 filings, dated to when each was filed.
Arcosa's stock activity this week centers on its pending acquisition by CRH, approved by shareholders at $150 per share, with the deal expected to close in Q1 2027. Shares have traded consistently below that offer price, near $146.52 to $146.75 across recent sessions, alongside a surge in trading volume. The company's Q2 2026 results showed revenue of $658.7 million, up 2% year-over-year but below the $687.5 million expected, while adjusted EPS of $1.13 missed the $1.18 estimate. Seven brokerages maintain a consensus "Hold" rating, with price targets cited at $141.25 following recent downward revisions.
The stock closed at $146.53, essentially flat on the day, and sits above both its 50-day average of $145.36 and 200-day average of $126.48, reflecting a one-year return of 59.9% and a six-month return of 42.5%. The GekkoIndex reads 44.6, placing the stock in the Distribution zone. Price stands 25% above Gekko Fair Value of $117.27, a gap wider than the 5% threshold typically flagged.
Over the next 20 trading days, the next earnings report is scheduled for 29 October 2026, falling just outside that window. The prior quarter's report drew a modest -0.2% reaction despite the EPS miss, with the company beating estimates in 6 of the last 8 quarters and an average absolute reaction of 7.3%. Seasonality across 5 years shows a 2.2% average move over comparable 20-day stretches, positive in 3 of those years. No insider, Congress, or unusual options activity appears in the current windows, leaving the pending CRH transaction as the dominant factor to monitor.
Written by AI and checked automatically against the figures on this page. Generated Sep 29, 2026 from the data above.
Arcosa scores 3 supportive, 0 mixed and 2 headwinds across the 5 checklist items with data.
Six things swing traders check before a 20-day hold, read from the latest data.
3 supportive0 mixed2 headwinds
Above 50 and 200-day
Close $146.53 is above the 50-day ($145.36) and 200-day ($126.48) averages, and the 50-day is above the 200-day.
See the chart44.6, Distribution
Reading 44.6 is in the Distribution zone.
See the GekkoIndex25.0% above
Price is 25% above Gekko Fair Value (more than 5% above).
See fair valueNo data
No insider, Congress or unusual options activity in the window.
See smart moneyReports in 30 days
Next report Oct 29, 2026, 30 days away — outside a typical 20-trading-day hold.
See earnings+2.2% on average
From this point in the calendar, the next 20 trading days averaged +2.2% over 5 years, rising in 3 of them.
See seasonalityA description of current data, not a recommendation. How this page works
Arcosa closed at $146.53 on Sep 28, 2026, +59.9% over the past year, inside a 52-week range of $89.03 to $146.92.
Use the left and right arrow keys to read daily values.
Put ACA on a Gekko watchlist and see its GekkoIndex, Gekko Fair Value and smart money signals update on the chart as they change.
Arcosa’s GekkoIndex — Gekko’s 0 to 100 smart money score — reads 44.6, in the Distribution zone, down 2 points over five sessions.
Down 2 points over five sessions, from the Neutral zone.
Reading for Sep 28, 2026
| Zone | Readings | 5 days | 20 days | ||
|---|---|---|---|---|---|
| Buying | 27 | +0.2% | +2.5% | ||
| Accumulation | 146 | +1.7% | +5.5% | ||
| Neutral | 459 | +0.4% | +1.5% | ||
| Distribution (current zone) | 34 | −1.0% | −2.5% | ||
| Selling | 6 | Too few readings yet | |||
Average ACA share-price change over the trading days after each daily reading in its GekkoIndex history. Across every stock Gekko tracks, Distribution readings averaged +1.2% over 20 days. Past behaviour doesn’t guarantee future results.
Distribution zone: Institutions potentially offloading. About the five zones →
Arcosa trades 25.0% above Gekko Fair Value of $117.27, so the shares are overvalued on Gekko’s estimate.
Gekko’s own estimate of what Arcosa shares are worth, recalculated every trading day.
$117.27
Gekko Fair Value, Sep 29, 2026
25.0% Overvalued
No open-market insider purchases were filed for Arcosa, and no Congress trades were disclosed, in the last 90 days.
Plus buybacks, unusual options and fund positions, each dated to when it became public.
No open-market insider purchases were filed for ACA in the last 90 days.
From Form 4 filings, dated to when each was filed.
No trades in ACA were disclosed by members of Congress in the last 90 days.
From congressional disclosures, which report amounts as ranges.
Arcosa has been buying back its own shares.
From company filings.
0of the funds Gekko tracks hold ACA.
Arcosa reports on Oct 29, 2026 (30 days away), and beat the EPS estimate in 6 of its last 8 reports.
Oct 29, 2026
30 days away
| Reported | EPS | Revenue | Move |
|---|---|---|---|
| Aug 5, 2026 | $1.13 est $1.19 | $658.7M est $687.5M | −0.2% |
| Apr 30, 2026 | $0.77 est $0.32 | $571.7M est $642.4M | +7.1% |
| Feb 26, 2026 | $1.15 est $0.95 | $716.7M est $719.5M | −15.1% |
| Oct 30, 2025 | $1.56 est $1.33 | $797.8M est $719.5M | +9.5% |
| Aug 7, 2025 | $1.27 est $1.05 | $736.9M est $774.8M | +13.2% |
| May 6, 2025 | $0.49 est $0.29 | $632.0M est $764.5M | −2.3% |
| Feb 27, 2025 | $0.46 est $0.79 | $666.2M est $690.3M | −10.2% |
| Oct 30, 2024 | $0.91 est $0.78 | $640.4M est $692.7M | −0.7% |
“Move” is the close of the first session after the report compared with the close of the last session before it, so it reads the same whether the company reported before the open or after the close.
Analysts’ average 12-month price target for Arcosa is $146.67, +0.1% from the last close, from 1 firm rating the stock in the last 90 days.
Each firm’s latest rating in the last 90 days: 1 firm.
| Date | Firm | Target | vs price |
|---|---|---|---|
| Aug 6 | Stephens | $150 | +2.4% |
Gekko doesn’t publish price predictions. These are analyst targets and historical base rates, which don’t guarantee future results.
Over the next 20 trading days from Sep 26, Arcosa averaged +2.2% across the last 5 years, rising in 3 of them.
| Window | Average | Years higher |
|---|---|---|
| Next 5 trading days | +0.7% | 1 of 5 |
| Next 10 trading days | +1.4% | 3 of 5 |
| Next 15 trading days | +2.5% | 4 of 5 |
| Next 20 trading days | +2.2% | 3 of 5 |
| Next 30 trading days | +5.8% | 4 of 5 |
For scale, ACA’s typical 20-trading-day move in either direction is about 5.4%.
Arcosa’s market cap is $7.20B, with a P/E ratio of 32.7 and revenue of $2.92B over the last twelve months.
Coverage of Arcosa this week reads negative: 1 positive, 2 neutral and 2 negative headlines.
Arcosa’s 6 largest industry peers by market value, with today’s move, GekkoIndex zone and gap to Gekko Fair Value.
| Stock | GekkoIndex zone | vs Fair Value |
|---|---|---|
| CRHCRH | Accumulation | 29.9% below |
| VMCVulcan Materials | Accumulation | 7.2% below |
| MLMMartin Marietta Materials | Accumulation | 8.0% below |
| AMRZAmrize | Accumulation | 32.4% below |
| JHXJames Hardie Industries | Accumulation | 10.9% below |
| EXPEagle Materials | Accumulation | 7.1% below |
A peer links to its own page where one exists.
Arcosa’s market cap is $7.20B at the Sep 28, 2026 close of $146.53, with 49.11M shares outstanding. The shares trade on a P/E ratio of 32.7.
The consensus analyst 12-month price target for Arcosa is $146.67, +0.1% from the last close. Of the 1 firm that rated the stock in the last 90 days, 0 rate it a buy, 1 a hold and 0 a sell. Gekko doesn’t publish price predictions of its own.
On Gekko’s estimate Arcosa is overvalued: the Sep 28, 2026 close of $146.53 is 25.0% above Gekko Fair Value of $117.27. Gekko Fair Value is recalculated every trading day, and a gap inside 5% either way counts as about fair value.
Arcosa is expected to report on Oct 29, 2026 (30 days away). Analysts expect earnings of $1.56 per share on revenue of $728.0M. Arcosa beat the earnings estimate in 6 of its last 8 reports, moving 7.3% on average across the report.
Arcosa’s 52-week high is $146.92 and its 52-week low is $89.03; it closed at $146.53 on Sep 28, 2026, +59.9% over the past year.
Gekko describes the data; it does not make buy or sell recommendations. On the swing-trade checklist, 3 of the 5 items with data read as supportive (trend, earnings risk and seasonality) and 2 as headwinds (gekkoindex and fair value). The checklist is a description of current data, not a recommendation.
During US trading hours the price at the top of the page is a delayed quote, refreshed every 15 minutes; everything else is rebuilt after each US market close. The GekkoIndex, Gekko Fair Value and the checklist are Gekko’s own, and the Gekko Brief is written by AI from this page’s data and checked against it before it is published. How Gekko’s data works →
Every GekkoIndex reading, insider trade, options bet and Congress disclosure plotted on the chart, plus the 5,800-name screener and trade planning tools.
Join 1,380 other traders using Gekko
Start Your FREE 7 Day Trial → Every feature unlocked. No credit card required.Type a ticker or company name. Press Esc to close.